A novel approach to SBRT patient quality assurance using EPID-based real-time transit dosimetry

ConclusionThis study demonstrates the feasibility of EPID for detecting the interplay effects. We recommend using thin computed tomography slices and adding sufficient tumor margin in order to limit the dosimetric organ motion in hypofractionated irradiation with preserved plan quality. In the presence of respiratory and gastrointestinal motion, tighter criteria and consequently using local gamma evaluation should be considered, especially for VMAT. This methodology offers a substantial step forward in in vivo dosimetry and the potential to distinguish errors depending on the gamma tolerances. Thus, the approach/prototype provides a fast and easy quality assurance procedure for treatment delivery verification.

http://link.springer.com/10.1007/s00066-019-01549-z

Source: Strahlentherapie und Onkologie - January 9, 2020 Category: Cancer & Oncology Source Type: research